Form 8-K - Current report:
SEC Accession No. 0001193125-24-263398
Filing Date
2024-11-21
Accepted
2024-11-21 16:07:02
Documents
15
Period of Report
2024-11-21
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d769907d8k.htm   iXBRL 8-K 41941
2 EX-99.1 d769907dex991.htm EX-99.1 43675
6 GRAPHIC g769907g1121141122429.jpg GRAPHIC 3587
  Complete submission text file 0001193125-24-263398.txt   230603

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA zyme-20241121.xsd EX-101.SCH 2857
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE zyme-20241121_lab.xml EX-101.LAB 17995
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE zyme-20241121_pre.xml EX-101.PRE 11266
17 EXTRACTED XBRL INSTANCE DOCUMENT d769907d8k_htm.xml XML 3629
Mailing Address 108 PATRIOT DRIVE, SUITE A MIDDLETOWN DE 19709
Business Address 108 PATRIOT DRIVE, SUITE A MIDDLETOWN DE 19709 302-274-8744
Zymeworks Inc. (Filer) CIK: 0001937653 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41535 | Film No.: 241484285
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)